Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 162 Fulvestrant 157 Trastuzumab 156 pembrolizumab 146 Letrozole 137 Carboplatin 118 pertuzumab 104 Capecitabine 104 Specimen Handling 102 Cyclophosphamide 102 Anastrozole 90 palbociclib 86 abemaciclib 82 Magnetic Resonance Spectroscopy 81 exemestane 76 Docetaxel 76 Tamoxifen 75 ribociclib 74 trastuzumab deruxtecan 68 Radiotherapy 62 Biopsy 59 Surveys and Questionnaires 55 Gemcitabine 53 130-nm albumin-bound paclitaxel 53 olaparib 52 sacituzumab govitecan 51 Blood Specimen Collection 51 Standard of Care 49 Taxes 48 eribulin 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Dipeptidyl-Peptidase IV Inhibitors × Breast × 1 year × Clear all

NCT07436663 2026-02-27

SGLT2i/DPPi

Tanta University

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡